FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression.

Am J Transplant

Department of Surgery, Duke University, Durham, North Carolina.

Published: April 2019

Download full-text PDF	Source
http://dx.doi.org/10.1111/ajt.15215	DOI Listing

Publication Analysis

fda jeopardizes

jeopardizes lives

lives lung

lung transplant

transplant recipients

recipients process

process severely

severely increases

increases cost

cost develop

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!